On February 16th, Gongdong Medical announced that its shareholder Taizhou Jinchi Investment Management Partnership Enterprise (Limited Partnership) and director and general manager Zhong Weifeng plan to reduce their holdings by no more than 1575784 shares and 302158 shares respectively through centralized bidding trading, with a total reduction of no more than 1.19% of the company’s total share capital.
Scan code to share